These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22913901)

  • 1. Managing diabetes in patients with chronic liver disease.
    Khan R; Foster GR; Chowdhury TA
    Postgrad Med; 2012 Jul; 124(4):130-7. PubMed ID: 22913901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diabetes mellitus and chronic liver diseases. Literature review (part 2): treatment features].
    Kalmykova ZA; Kononenko IV; Mayorov AY
    Ter Arkh; 2019 Dec; 91(12):115-121. PubMed ID: 32598598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acarbose is a promising therapeutic strategy for the treatment of patients with nonalcoholic steatohepatitis (NASH).
    Yamagishi S; Nakamura K; Inoue H
    Med Hypotheses; 2005; 65(2):377-9. PubMed ID: 15922116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes in chronic liver disease: from old concepts to new evidence.
    Picardi A; D'Avola D; Gentilucci UV; Galati G; Fiori E; Spataro S; Afeltra A
    Diabetes Metab Res Rev; 2006; 22(4):274-83. PubMed ID: 16506276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus, obesity, and hepatic steatosis.
    Youssef W; McCullough AJ
    Semin Gastrointest Dis; 2002 Jan; 13(1):17-30. PubMed ID: 11944630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing diabetes and liver disease association.
    Hamed AE; Elsahar M; Elwan NM; El-Nakeep S; Naguib M; Soliman HH; Ahmed Aboubakr A; AbdelMaqsod A; Sedrak H; Assaad SN; Elwakil R; Esmat G; Salh S; Mostafa T; Mogawer S; Sadek SE; Saber MM; Ezelarab H; Mahmoud AA; Sultan S; El Kassas M; Kamal E; ElSayed NM; Moussa S
    Arab J Gastroenterol; 2018 Dec; 19(4):166-179. PubMed ID: 30420265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic liver disease in diabetes mellitus.
    Amarapurkar D; Das HS
    Trop Gastroenterol; 2002; 23(1):3-5. PubMed ID: 12170918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of diabetes in the hospital.
    Fonseca V
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S10-7. PubMed ID: 17224872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using insulin as a drug rather than as a replacement hormone during acute illness: a new paradigm.
    Pantaleo A; Zonszein J
    Heart Dis; 2003; 5(5):323-33. PubMed ID: 14503930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolidinediones and the liver in humans.
    Yki-Järvinen H
    Curr Opin Lipidol; 2009 Dec; 20(6):477-83. PubMed ID: 19779336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic liver disease related to impaired glucose tolerance].
    Saibara T
    Rinsho Byori; 2010 Oct; 58(10):1021-5. PubMed ID: 21077292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-glycoside biomarker of apolipoprotein C3: responsiveness to obesity, bariatric surgery, and therapy with metformin, to chronic or severe liver disease and to mortality in severe sepsis and graft vs host disease.
    Harvey SB; Zhang Y; Wilson-Grady J; Monkkonen T; Nelsestuen GL; Kasthuri RS; Verneris MR; Lund TC; Ely EW; Bernard GR; Zeisler H; Homoncik M; Jilma B; Swan T; Kellogg TA
    J Proteome Res; 2009 Feb; 8(2):603-12. PubMed ID: 19055479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study.
    Stepanova M; Rafiq N; Younossi ZM
    Gut; 2010 Oct; 59(10):1410-5. PubMed ID: 20660697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.
    Wong VW; Hui AY; Tsang SW; Chan JL; Wong GL; Chan AW; So WY; Cheng AY; Tong PC; Chan FK; Sung JJ; Chan HL
    Aliment Pharmacol Ther; 2006 Oct; 24(8):1215-22. PubMed ID: 17014580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic fatty liver disease: pharmacologic and surgical options.
    Parikh N; Ahmad J
    Gastroenterol Clin North Am; 2011 Sep; 40(3):541-59. PubMed ID: 21893273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of NAFLD.
    Trappoliere M; Tuccillo C; Federico A; Di Leva A; Niosi M; D'Alessio C; Capasso R; Coppola F; Dauria M; Loguercio C
    Eur Rev Med Pharmacol Sci; 2005; 9(5):299-304. PubMed ID: 16231594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Costs of the treatment of hyperglycemia in patients with diabetes mellitus. The impact of age, type of therapy and complications: results of the German CoDiM study].
    von Ferber L; Köster I; Hauner H
    Med Klin (Munich); 2006 May; 101(5):384-93. PubMed ID: 16685485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes and liver disease: an ominous association.
    Moscatiello S; Manini R; Marchesini G
    Nutr Metab Cardiovasc Dis; 2007 Jan; 17(1):63-70. PubMed ID: 17164082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin strategies for managing inpatient and outpatient hyperglycemia and diabetes.
    Moghissi ES
    Mt Sinai J Med; 2008 Dec; 75(6):558-66. PubMed ID: 19021195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.